Gastric Surgery Clinical Trial
Official title:
Transgastric Bacterial Contamination of the Abdomen
Verified date | December 2011 |
Source | Ohio State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The purpose of this study is to evaluate whether creating a gastrotomy (hole in the stomach)
during gastric surgery increases a patient's risk of intra-abdominal infection.
We hypothesize that a gastrotomy does not contaminate the abdomen with clinically
significant bacterial pathogens.
Status | Completed |
Enrollment | 50 |
Est. completion date | October 2007 |
Est. primary completion date | October 2007 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - any patient undergoing roux-en-y gastric bypass Exclusion Criteria: - lack of consent |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | The Ohio State University Center for Minimally Invasive Surgery | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Jeffrey Hazey |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quantitative and qualitative measure of the bacterial load and bacterial contamination of the abdomen during laparoscopic roux-en-y gastric bypass surgery while the gastrotomy is open to the abdominal cavity. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05759689 -
Fat Supplementation on Dumping Syndrome Related Symptoms After Gastric Surgery
|
N/A | |
Completed |
NCT00929461 -
Impact of Omega-3 Fatty Acids on Lactate
|
N/A |